444 related articles for article (PubMed ID: 28301304)
1. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
[TBL] [Abstract][Full Text] [Related]
2. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
Khurana N; Gajbhiye A
Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
Abdelsalam RM; Safar MM
J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
[TBL] [Abstract][Full Text] [Related]
5. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease.
El-Sayed EK; Ahmed A; Morsy EE; Nofal S
Hum Exp Toxicol; 2019 Feb; 38(2):173-184. PubMed ID: 30001633
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
8. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
[TBL] [Abstract][Full Text] [Related]
11. Caffeine alleviates anxiety-like behavior and brainstem lesions in a rotenone-induced rat model of Parkinson's disease.
Adeyeye TA; Babatunde BR; Ehireme SE; Shallie PD
J Chem Neuroanat; 2023 Oct; 132():102315. PubMed ID: 37481171
[TBL] [Abstract][Full Text] [Related]
12. Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.
Bandookwala M; Sahu AK; Thakkar D; Sharma M; Khairnar A; Sengupta P
Neurosci Lett; 2019 Oct; 711():134438. PubMed ID: 31422100
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antioxidant and anti-inflammatory efficacy of caffeine in rat model of neurotoxicity.
Hosny EN; Sawie HG; Elhadidy ME; Khadrawy YA
Nutr Neurosci; 2019 Nov; 22(11):789-796. PubMed ID: 29514562
[No Abstract] [Full Text] [Related]
14. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
15. Oral Supplements of
Mohammed NA; Abdou HM; Tass MA; Alfwuaires M; Abdel-Moneim AM; Essawy AE
Curr Pharm Biotechnol; 2020; 21(12):1259-1268. PubMed ID: 32196446
[TBL] [Abstract][Full Text] [Related]
16. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
Sakamula R; Yata T; Thong-Asa W
Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar neurochemical and histopathological changes in rat model of Parkinson's disease induced by intrastriatal injection of rotenone.
Khadrawy YA; Mourad IM; Mohammed HS; Noor NA; Aboul Ezz HS
Gen Physiol Biophys; 2017 Jan; 36(1):99-108. PubMed ID: 27901474
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
20. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
